02/01/2019 |
KUVAN NDA #022181 |
SUPPL-17 |
SAPROPTERIN DIHYDROCHLORIDE |
BIOMARIN PHARM |
Labeling |
Approval |
02/01/2019 |
AZITHROMYCIN ANDA #065209 |
SUPPL-25 |
AZITHROMYCIN |
SANDOZ |
Labeling |
Approval |
02/01/2019 |
AZITHROMYCIN ANDA #065209 |
SUPPL-26 |
AZITHROMYCIN |
SANDOZ |
Labeling |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-4 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-7 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-9 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-11 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
02/01/2019 |
OPDIVO BLA #125554 |
SUPPL-72 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
02/01/2019 |
XARELTO NDA #202439 |
SUPPL-29 |
RIVAROXABAN |
JANSSEN PHARMS |
Labeling |
Approval |
02/01/2019 |
OPSUMIT NDA #204410 |
SUPPL-18 |
MACITENTAN |
ACTELION |
REMS |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #205761 |
SUPPL-2 |
RABEPRAZOLE SODIUM |
AUROBINDO PHARMA |
Labeling |
Approval |
02/01/2019 |
RABEPRAZOLE SODIUM ANDA #205761 |
SUPPL-3 |
RABEPRAZOLE SODIUM |
AUROBINDO PHARMA |
Labeling |
Approval |
02/01/2019 |
DICYCLOMINE HYDROCHLORIDE ANDA #206468 |
ORIG-1 |
DICYCLOMINE HYDROCHLORIDE |
NEXUS |
|
Approval |
02/01/2019 |
OXYCODONE HYDROCHLORIDE ANDA #206914 |
ORIG-1 |
OXYCODONE HYDROCHLORIDE |
PHARM ASSOC |
|
Approval |
02/01/2019 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-2 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
02/01/2019 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-3 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
02/01/2019 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #208737 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
CEDIPROF INC |
|
Approval |
02/01/2019 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE NDA #210787 |
ORIG-1 |
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE |
LAURUS LABS LTD |
Type 4 - New Combination |
Tentative Approval |
02/01/2019 |
BACLOFEN ANDA #211555 |
ORIG-1 |
BACLOFEN |
EYWA PHARMA |
|
Approval |
02/01/2019 |
JEUVEAU BLA #761085 |
ORIG-1 |
PRABOTULINUMTOXINA-XVFS |
EVOLUS INC |
|
Approval |
02/02/2019 |
METFORMIN HYDROCHLORIDE ANDA #076033 |
SUPPL-16 |
METFORMIN HYDROCHLORIDE |
ATLAS PHARMS LLC |
Labeling |
Approval |
02/02/2019 |
METFORMIN HYDROCHLORIDE ANDA #076033 |
SUPPL-20 |
METFORMIN HYDROCHLORIDE |
ATLAS PHARMS LLC |
Labeling |
Approval |
02/02/2019 |
LEVOCETIRIZINE DIHYDROCHLORIDE ANDA #090362 |
SUPPL-7 |
LEVOCETIRIZINE DIHYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
02/02/2019 |
LEVOCETIRIZINE DIHYDROCHLORIDE ANDA #090362 |
SUPPL-8 |
LEVOCETIRIZINE DIHYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
02/02/2019 |
METFORMIN HYDROCHLORIDE ANDA #091184 |
SUPPL-10 |
METFORMIN HYDROCHLORIDE |
ALKEM |
Labeling |
Approval |
02/02/2019 |
METFORMIN HYDROCHLORIDE ANDA #091184 |
SUPPL-12 |
METFORMIN HYDROCHLORIDE |
ALKEM |
Labeling |
Approval |
02/02/2019 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-17 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
MACLEODS PHARMS LTD |
Labeling |
Approval |
02/02/2019 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-24 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
MACLEODS PHARMS LTD |
Labeling |
Approval |
02/02/2019 |
IRBESARTAN; HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-17 |
IRBESARTAN: HYDROCHLOROTHIAZIDE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
02/02/2019 |
IRBESARTAN; HYDROCHLOROTHIAZIDE ANDA #202414 |
SUPPL-24 |
IRBESARTAN: HYDROCHLOROTHIAZIDE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
02/04/2019 |
ANTARA (MICRONIZED) NDA #021695 |
SUPPL-18 |
FENOFIBRATE |
LUPIN |
Manufacturing (CMC) |
Approval |
02/04/2019 |
ACETAMINOPHEN AND CODEINE PHOSPHATE ANDA #089673 |
SUPPL-27 |
ACETAMINOPHEN; CODEINE PHOSPHATE |
RHODES PHARMS |
REMS |
Approval |
02/04/2019 |
POTASSIUM CHLORIDE NDA #206814 |
SUPPL-7 |
POTASSIUM CHLORIDE |
GENUS LIFESCIENCES |
Labeling |
Approval |
02/04/2019 |
LABETALOL HYDROCHLORIDE ANDA #207863 |
ORIG-1 |
LABETALOL HYDROCHLORIDE |
EYWA |
|
Approval |
02/04/2019 |
VEMLIDY NDA #208464 |
SUPPL-7 |
TENOFOVIR ALAFENAMIDE FUMARATE |
GILEAD SCIENCES INC |
Efficacy |
Approval |
02/04/2019 |
ACYCLOVIR ANDA #208702 |
ORIG-1 |
ACYCLOVIR |
PADAGIS ISRAEL |
|
Approval |
02/04/2019 |
XEPI NDA #208945 |
SUPPL-1 |
OZENOXACIN |
FERRER INTERNACIONAL |
Labeling |
Approval |
02/04/2019 |
LEVOMILNACIPRAN HYDROCHLORIDE ANDA #210790 |
ORIG-1 |
LEVOMILNACIPRAN HYDROCHLORIDE |
AMNEAL PHARMS CO |
|
Approval |
02/04/2019 |
DAPAGLIFLOZIN ANDA #211541 |
ORIG-1 |
DAPAGLIFLOZIN |
TEVA PHARMS USA INC |
|
Tentative Approval |
02/04/2019 |
OXYCODONE HYDROCHLORIDE ANDA #211749 |
ORIG-1 |
OXYCODONE HYDROCHLORIDE |
ALKEM LABS LTD |
|
Approval |
02/05/2019 |
AVANDIA NDA #021071 |
SUPPL-52 |
ROSIGLITAZONE MALEATE |
WOODWARD |
Labeling |
Approval |
02/05/2019 |
LEVOFLOXACIN ANDA #204968 |
ORIG-1 |
LEVOFLOXACIN |
HEC PHARM |
|
Approval |
02/05/2019 |
TADALAFIL ANDA #206286 |
ORIG-1 |
TADALAFIL |
AUROBINDO PHARMA LTD |
|
Approval |
02/05/2019 |
DYANAVEL XR NDA #208147 |
SUPPL-5 |
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE |
TRIS PHARMA INC |
Efficacy |
Approval |
02/05/2019 |
TADALAFIL ANDA #209907 |
ORIG-1 |
TADALAFIL |
HETERO LABS LTD III |
|
Approval |
02/05/2019 |
ALYQ ANDA #209942 |
ORIG-1 |
TADALAFIL |
TEVA PHARMS USA |
|
Approval |
02/05/2019 |
TADALAFIL ANDA #210145 |
ORIG-1 |
TADALAFIL |
DR REDDYS |
|
Approval |
02/05/2019 |
TADALAFIL ANDA #210255 |
ORIG-1 |
TADALAFIL |
CIPLA |
|
Approval |
02/05/2019 |
TADALAFIL ANDA #210392 |
ORIG-1 |
TADALAFIL |
AJANTA PHARMA LTD |
|
Approval |
02/05/2019 |
TADALAFIL ANDA #210572 |
ORIG-1 |
TADALAFIL |
CHARTWELL RX |
|
Approval |
02/05/2019 |
ESTRADIOL ANDA #211293 |
ORIG-1 |
ESTRADIOL |
AMNEAL |
|
Approval |
02/06/2019 |
BUTISOL SODIUM NDA #000793 |
SUPPL-26 |
BUTABARBITAL SODIUM |
MYLAN SPECIALITY LP |
Labeling |
Approval |
02/06/2019 |
HALCION NDA #017892 |
SUPPL-54 |
TRIAZOLAM |
PFIZER |
Labeling |
Approval |
02/06/2019 |
RESTORIL NDA #018163 |
SUPPL-65 |
TEMAZEPAM |
SPECGX LLC |
Labeling |
Approval |
02/06/2019 |
DORAL NDA #018708 |
SUPPL-25 |
QUAZEPAM |
GALT PHARMS |
Labeling |
Approval |
02/06/2019 |
CLARITIN NDA #019658 |
SUPPL-56 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/06/2019 |
CLARITIN HIVES RELIEF NDA #019658 |
SUPPL-56 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/06/2019 |
AMBIEN NDA #019908 |
SUPPL-45 |
ZOLPIDEM TARTRATE |
SANOFI AVENTIS US |
Labeling |
Approval |
02/06/2019 |
SONATA NDA #020859 |
SUPPL-15 |
ZALEPLON |
PFIZER |
Labeling |
Approval |
02/06/2019 |
LUNESTA NDA #021476 |
SUPPL-37 |
ESZOPICLONE |
WAYLIS THERAP |
Labeling |
Approval |
02/06/2019 |
AMBIEN CR NDA #021774 |
SUPPL-26 |
ZOLPIDEM TARTRATE |
SANOFI AVENTIS US |
Labeling |
Approval |
02/06/2019 |
EDLUAR NDA #021997 |
SUPPL-10 |
ZOLPIDEM TARTRATE |
MYLAN SPECIALITY LP |
Labeling |
Approval |
02/06/2019 |
ZOLPIMIST NDA #022196 |
SUPPL-11 |
ZOLPIDEM TARTRATE |
AYTU |
Labeling |
Approval |
02/06/2019 |
INTERMEZZO NDA #022328 |
SUPPL-7 |
ZOLPIDEM TARTRATE |
PURDUE PHARMA |
Labeling |
Approval |
02/06/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #070345 |
SUPPL-20 |
FLURAZEPAM HYDROCHLORIDE |
RISING |
Labeling |
Approval |
02/06/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #070454 |
SUPPL-19 |
FLURAZEPAM HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
02/06/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #070455 |
SUPPL-19 |
FLURAZEPAM HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
02/06/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #072368 |
SUPPL-6 |
FLURAZEPAM HYDROCHLORIDE |
CHARTWELL RX |
Labeling |
Approval |
02/06/2019 |
ESTAZOLAM ANDA #074826 |
SUPPL-18 |
ESTAZOLAM |
NOVITIUM PHARMA |
Labeling |
Approval |
02/06/2019 |
ESTAZOLAM ANDA #074921 |
SUPPL-16 |
ESTAZOLAM |
DR REDDYS LABS SA |
Labeling |
Approval |
02/06/2019 |
NEMBUTAL SODIUM ANDA #083245 |
SUPPL-14 |
PENTOBARBITAL SODIUM |
EPIC PHARMA LLC |
Labeling |
Approval |
02/06/2019 |
NEMBUTAL SODIUM ANDA #084093 |
SUPPL-12 |
PENTOBARBITAL SODIUM |
EPIC PHARMA LLC |
Labeling |
Approval |
02/06/2019 |
NEMBUTAL SODIUM ANDA #084095 |
SUPPL-8 |
PENTOBARBITAL SODIUM |
EPIC PHARMA LLC |
Labeling |
Approval |
02/06/2019 |
SODIUM BUTABARBITAL ANDA #085849 |
SUPPL-6 |
BUTABARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
SODIUM BUTABARBITAL ANDA #085866 |
SUPPL-7 |
BUTABARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
BUTALAN ANDA #085880 |
SUPPL-1 |
BUTABARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
SODIUM BUTABARBITAL ANDA #085881 |
SUPPL-5 |
BUTABARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
PENTOBARBITAL SODIUM ANDA #085915 |
SUPPL-3 |
PENTOBARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
PENTOBARBITAL SODIUM ANDA #085937 |
SUPPL-3 |
PENTOBARBITAL SODIUM |
LANNETT |
Labeling |
Approval |
02/06/2019 |
SYLEVIA ANDA #202988 |
ORIG-1 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
SUN PHARM |
|
Approval |
02/06/2019 |
STRIBILD NDA #203100 |
SUPPL-34 |
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
GILEAD SCIENCES INC |
Labeling |
Approval |
02/06/2019 |
NALBUPHINE HYDROCHLORIDE ANDA #206506 |
ORIG-1 |
NALBUPHINE HYDROCHLORIDE |
RISING |
|
Approval |
02/06/2019 |
OXYBUTYNIN CHLORIDE ANDA #211062 |
ORIG-1 |
OXYBUTYNIN CHLORIDE |
EYWA |
|
Approval |
02/06/2019 |
CABLIVI BLA #761112 |
ORIG-1 |
CAPLACIZUMAB-YHDP |
ABLYNX NV |
|
Approval |
02/07/2019 |
DIFLUCAN NDA #019949 |
SUPPL-65 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
02/07/2019 |
DIFLUCAN NDA #020090 |
SUPPL-47 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #076885 |
SUPPL-4 |
RABEPRAZOLE SODIUM |
MYLAN |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #076885 |
SUPPL-5 |
RABEPRAZOLE SODIUM |
MYLAN |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #076885 |
SUPPL-6 |
RABEPRAZOLE SODIUM |
MYLAN |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #076885 |
SUPPL-8 |
RABEPRAZOLE SODIUM |
MYLAN |
Labeling |
Approval |
02/07/2019 |
BICALUTAMIDE ANDA #078634 |
SUPPL-6 |
BICALUTAMIDE |
WATSON LABS TEVA |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #090678 |
SUPPL-5 |
RABEPRAZOLE SODIUM |
LANNETT CO INC |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #090678 |
SUPPL-6 |
RABEPRAZOLE SODIUM |
LANNETT CO INC |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #090678 |
SUPPL-7 |
RABEPRAZOLE SODIUM |
LANNETT CO INC |
Labeling |
Approval |
02/07/2019 |
RABEPRAZOLE SODIUM ANDA #090678 |
SUPPL-10 |
RABEPRAZOLE SODIUM |
LANNETT CO INC |
Labeling |
Approval |
02/07/2019 |
CARBAMAZEPINE ANDA #205571 |
ORIG-1 |
CARBAMAZEPINE |
ZYDUS PHARMS |
|
Approval |
02/07/2019 |
NICOTINE POLACRILEX ANDA #207868 |
ORIG-1 |
NICOTINE POLACRILEX |
PLD ACQUISITIONS |
|
Approval |
02/07/2019 |
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE ANDA #209281 |
ORIG-1 |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
ACCORD HLTHCARE |
|
Approval |
02/07/2019 |
ESKATA NDA #209305 |
SUPPL-1 |
HYDROGEN PEROXIDE |
ACLARIS |
Labeling |
Approval |
02/07/2019 |
OXYCODONE HYDROCHLORIDE ANDA #211748 |
ORIG-1 |
OXYCODONE HYDROCHLORIDE |
ALKEM LABS LTD |
|
Approval |
02/08/2019 |
CANCIDAS NDA #021227 |
SUPPL-39 |
CASPOFUNGIN ACETATE |
MERCK |
Labeling |
Approval |
02/08/2019 |
DOXYCYCLINE ANDA #203278 |
ORIG-1 |
DOXYCYCLINE |
AMNEAL PHARMS |
|
Tentative Approval |
02/08/2019 |
SEVELAMER HYDROCHLORIDE ANDA #204724 |
ORIG-1 |
SEVELAMER HYDROCHLORIDE |
GLENMARK PHARMS LTD |
|
Approval |
02/08/2019 |
IMATINIB MESYLATE ANDA #205990 |
ORIG-1 |
IMATINIB MESYLATE |
BRECKENRIDGE |
|
Approval |
02/08/2019 |
IMATINIB MESYLATE ANDA #207495 |
ORIG-1 |
IMATINIB MESYLATE |
AMNEAL PHARMS |
|
Approval |
02/08/2019 |
DEFERIPRONE ANDA #208800 |
ORIG-1 |
DEFERIPRONE |
TARO |
|
Approval |
02/08/2019 |
TRIENTINE HYDROCHLORIDE ANDA #210619 |
ORIG-1 |
TRIENTINE HYDROCHLORIDE |
AMNEAL |
|
Approval |
02/08/2019 |
COLCHICINE ANDA #211250 |
ORIG-1 |
COLCHICINE |
ALKEM LABS LTD |
|
Approval |
02/08/2019 |
FLUOXETINE HYDROCHLORIDE ANDA #211632 |
ORIG-1 |
FLUOXETINE HYDROCHLORIDE |
LUPIN LTD |
|
Approval |
02/08/2019 |
ATORVASTATIN CALCIUM ANDA #211933 |
ORIG-1 |
ATORVASTATIN CALCIUM |
MSN |
|
Approval |
02/08/2019 |
DARZALEX BLA #761036 |
SUPPL-16 |
DARATUMUMAB |
JANSSEN BIOTECH |
|
Approval |
02/11/2019 |
VANTAS NDA #021732 |
SUPPL-22 |
HISTRELIN ACETATE |
ENDO PHARM |
Labeling |
Approval |
02/11/2019 |
NOVOLOG MIX 50/50 BLA #021810 |
SUPPL-15 |
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT |
NOVO NORDISK INC |
|
Approval |
02/11/2019 |
CAYSTON NDA #050814 |
SUPPL-21 |
AZTREONAM |
GILEAD |
Labeling |
Approval |
02/11/2019 |
TRIAMTERENE AND HYDROCHLOROTHIAZIDE ANDA #208358 |
ORIG-1 |
HYDROCHLOROTHIAZIDE; TRIAMTERENE |
CADILA |
|
Approval |
02/11/2019 |
LO-MALMOREDE ANDA #209548 |
ORIG-1 |
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE |
NOVAST LABS |
|
Approval |
02/11/2019 |
FENOFIBRATE ANDA #209660 |
ORIG-1 |
FENOFIBRATE |
CHARTWELL RX |
|
Approval |
02/11/2019 |
OMEPRAZOLE ANDA #210070 |
ORIG-1 |
OMEPRAZOLE |
APOTEX |
|
Approval |
02/11/2019 |
TRIAMCINOLONE ACETONIDE ANDA #210346 |
ORIG-1 |
TRIAMCINOLONE ACETONIDE |
STRIDES PHARMA |
|
Approval |
02/11/2019 |
DICYCLOMINE HYDROCHLORIDE ANDA #210788 |
ORIG-1 |
DICYCLOMINE HYDROCHLORIDE |
HIKMA |
|
Approval |
02/12/2019 |
ANCOBON NDA #017001 |
SUPPL-33 |
FLUCYTOSINE |
BAUSCH |
Labeling |
Approval |
02/12/2019 |
LINEZOLID ANDA #078845 |
SUPPL-1 |
LINEZOLID |
RISING |
Labeling |
Approval |
02/12/2019 |
LINEZOLID ANDA #078845 |
SUPPL-2 |
LINEZOLID |
RISING |
Labeling |
Approval |
02/12/2019 |
AZACITIDINE ANDA #204949 |
SUPPL-2 |
AZACITIDINE |
MYLAN INSTITUTIONAL |
Labeling |
Approval |
02/12/2019 |
AZACITIDINE ANDA #204949 |
SUPPL-3 |
AZACITIDINE |
MYLAN INSTITUTIONAL |
Labeling |
Approval |
02/12/2019 |
MYCOPHENOLATE MOFETIL ANDA #210370 |
ORIG-1 |
MYCOPHENOLATE MOFETIL |
VISTAPHARM |
|
Approval |
02/13/2019 |
INOMAX NDA #020845 |
SUPPL-20 |
NITRIC OXIDE |
MALLINCKRODT HOSP |
Labeling |
Approval |
02/13/2019 |
EMBELINE ANDA #074221 |
SUPPL-8 |
CLOBETASOL PROPIONATE |
HIKMA |
Manufacturing (CMC) |
Approval |
02/13/2019 |
CIMETIDINE HYDROCHLORIDE ANDA #074664 |
SUPPL-2 |
CIMETIDINE HYDROCHLORIDE |
PAI HOLDINGS PHARM |
Manufacturing (CMC) |
Approval |
02/13/2019 |
OFLOXACIN ANDA #076513 |
SUPPL-21 |
OFLOXACIN |
APOTEX INC |
Manufacturing (CMC) |
Approval |
02/13/2019 |
EGATEN NDA #208711 |
ORIG-1 |
TRICLABENDAZOLE |
NOVARTIS |
Type 1 - New Molecular Entity |
Approval |
02/13/2019 |
MOXIFLOXACIN HYDROCHLORIDE ANDA #209469 |
ORIG-1 |
MOXIFLOXACIN HYDROCHLORIDE |
ALEMBIC |
|
Approval |
02/13/2019 |
FLUOCINOLONE ACETONIDE ANDA #209913 |
ORIG-1 |
FLUOCINOLONE ACETONIDE |
ENCUBE ETHICALS |
|
Approval |
02/13/2019 |
KISQALI FEMARA CO-PACK (COPACKAGED) NDA #209935 |
SUPPL-2 |
LETROZOLE; RIBOCICLIB SUCCINATE |
NOVARTIS |
Efficacy |
Approval |
02/14/2019 |
M.V.I. PEDIATRIC NDA #018920 |
SUPPL-38 |
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E |
HOSPIRA |
Labeling |
Approval |
02/14/2019 |
SPIRIVA RESPIMAT NDA #021936 |
SUPPL-12 |
TIOTROPIUM BROMIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
02/14/2019 |
AZITHROMYCIN ANDA #065211 |
SUPPL-30 |
AZITHROMYCIN |
SANDOZ |
Labeling |
Approval |
02/14/2019 |
AZITHROMYCIN ANDA #065212 |
SUPPL-28 |
AZITHROMYCIN |
SANDOZ |
Labeling |
Approval |
02/14/2019 |
METFORMIN HYDROCHLORIDE ANDA #077095 |
SUPPL-23 |
METFORMIN HYDROCHLORIDE |
AUROBINDO |
Labeling |
Approval |
02/14/2019 |
METFORMIN HYDROCHLORIDE ANDA #077095 |
SUPPL-24 |
METFORMIN HYDROCHLORIDE |
AUROBINDO |
Labeling |
Approval |
02/14/2019 |
DESMOPRESSIN ACETATE ANDA #091374 |
ORIG-1 |
DESMOPRESSIN ACETATE |
AM REGENT |
|
Approval |
02/14/2019 |
ENBREL BLA #103795 |
SUPPL-5571 |
ETANERCEPT |
IMMUNEX |
|
Approval |
02/14/2019 |
NORGESTIMATE AND ETHINYL ESTRADIOL ANDA #205630 |
SUPPL-3 |
ETHINYL ESTRADIOL; NORGESTIMATE |
LUPIN LTD |
Labeling |
Approval |
02/14/2019 |
NORGESTIMATE AND ETHINYL ESTRADIOL ANDA #205630 |
SUPPL-4 |
ETHINYL ESTRADIOL; NORGESTIMATE |
LUPIN LTD |
Manufacturing (CMC) |
Approval |
02/14/2019 |
GEMCITABINE HYDROCHLORIDE ANDA #210383 |
ORIG-1 |
GEMCITABINE HYDROCHLORIDE |
NOVAST LABS |
|
Approval |
02/14/2019 |
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE ANDA #210676 |
ORIG-1 |
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN |
AUROBINDO PHARMA LTD |
|
Approval |
02/15/2019 |
ELIGARD KIT NDA #021343 |
SUPPL-39 |
LEUPROLIDE ACETATE |
TOLMAR |
Labeling |
Approval |
02/15/2019 |
ELIGARD KIT NDA #021379 |
SUPPL-41 |
LEUPROLIDE ACETATE |
TOLMAR |
Labeling |
Approval |
02/15/2019 |
ELIGARD KIT NDA #021488 |
SUPPL-36 |
LEUPROLIDE ACETATE |
TOLMAR |
Labeling |
Approval |
02/15/2019 |
ELIGARD KIT NDA #021731 |
SUPPL-37 |
LEUPROLIDE ACETATE |
TOLMAR |
Labeling |
Approval |
02/15/2019 |
BYDUREON NDA #022200 |
SUPPL-28 |
EXENATIDE SYNTHETIC |
ASTRAZENECA AB |
Efficacy |
Approval |
02/15/2019 |
BYDUREON PEN NDA #022200 |
SUPPL-28 |
EXENATIDE SYNTHETIC |
ASTRAZENECA AB |
Efficacy |
Approval |
02/15/2019 |
ONTAK BLA #103767 |
SUPPL-5143 |
DENILEUKIN DIFTITOX |
EISAI INC |
|
Approval |
02/15/2019 |
KEYTRUDA BLA #125514 |
SUPPL-40 |
PEMBROLIZUMAB |
MERCK SHARP DOHME |
|
Approval |
02/15/2019 |
REPATHA BLA #125522 |
SUPPL-19 |
EVOLOCUMAB |
AMGEN INC |
|
Approval |
02/15/2019 |
REPATHA BLA #125522 |
SUPPL-22 |
EVOLOCUMAB |
AMGEN INC |
|
Approval |
02/15/2019 |
OXALIPLATIN ANDA #202922 |
ORIG-2 |
OXALIPLATIN |
SUN PHARM |
|
Approval |
02/15/2019 |
PROCHLORPERAZINE EDISYLATE ANDA #204860 |
ORIG-1 |
PROCHLORPERAZINE EDISYLATE |
NEXUS |
|
Approval |
02/15/2019 |
BENDAMUSTINE HYDROCHLORIDE ANDA #205757 |
ORIG-1 |
BENDAMUSTINE HYDROCHLORIDE |
PHARMASCIENCE INC |
|
Tentative Approval |
02/15/2019 |
RISEDRONATE SODIUM ANDA #207516 |
ORIG-1 |
RISEDRONATE SODIUM |
HANGZHOU BINJIANG |
|
Approval |
02/15/2019 |
BYDUREON BCISE NDA #209210 |
SUPPL-1 |
EXENATIDE SYNTHETIC |
ASTRAZENECA AB |
Efficacy |
Approval |
02/15/2019 |
CLOTRIMAZOLE ANDA #209815 |
ORIG-1 |
CLOTRIMAZOLE |
NOVITIUM PHARMA |
|
Approval |
02/15/2019 |
CLOBETASOL PROPIONATE ANDA #210809 |
ORIG-1 |
CLOBETASOL PROPIONATE |
GLENMARK PHARMS LTD |
|
Approval |
02/15/2019 |
VANCOMYCIN HYDROCHLORIDE NDA #211962 |
ORIG-1 |
VANCOMYCIN HYDROCHLORIDE |
XELLIA PHARMS APS |
Type 5 - New Formulation or New Manufacturer |
Approval |
02/19/2019 |
GEMFIBROZIL ANDA #075034 |
SUPPL-29 |
GEMFIBROZIL |
APOTEX |
Labeling |
Approval |
02/19/2019 |
GEMFIBROZIL ANDA #202726 |
SUPPL-6 |
GEMFIBROZIL |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
02/19/2019 |
IBRANCE NDA #207103 |
SUPPL-10 |
PALBOCICLIB |
PFIZER |
Labeling |
Approval |
02/19/2019 |
TELMISARTAN ANDA #207843 |
ORIG-1 |
TELMISARTAN |
HISUN PHARM HANGZHOU |
|
Approval |
02/19/2019 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #207896 |
SUPPL-2 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
HISUN PHARM HANGZHOU |
Labeling |
Approval |
02/19/2019 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE ANDA #207896 |
SUPPL-3 |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
HISUN PHARM HANGZHOU |
Labeling |
Approval |
02/19/2019 |
AZITHROMYCIN ANDA #209044 |
SUPPL-1 |
AZITHROMYCIN |
SUNSHINE |
Manufacturing (CMC) |
Approval |
02/19/2019 |
AZITHROMYCIN ANDA #209045 |
SUPPL-1 |
AZITHROMYCIN |
SUNSHINE |
Manufacturing (CMC) |
Approval |
02/19/2019 |
ACETAZOLAMIDE ANDA #210423 |
ORIG-1 |
ACETAZOLAMIDE |
ALEMBIC |
|
Approval |
02/19/2019 |
LEVOTHYROXINE SODIUM ANDA #210831 |
ORIG-1 |
LEVOTHYROXINE SODIUM |
AMNEAL |
|
Approval |
02/19/2019 |
BUPIVACAINE HYDROCHLORIDE ANDA #211096 |
ORIG-1 |
BUPIVACAINE HYDROCHLORIDE |
CIVICA |
|
Approval |
02/19/2019 |
COLCHICINE ANDA #211519 |
ORIG-1 |
COLCHICINE |
ZYDUS PHARMS |
|
Approval |
02/19/2019 |
ETHOSUXIMIDE ANDA #211928 |
ORIG-1 |
ETHOSUXIMIDE |
STRIDES PHARMA |
|
Approval |
02/20/2019 |
NAPROXEN SODIUM NDA #021920 |
SUPPL-23 |
NAPROXEN SODIUM |
BIONPHARMA |
Labeling |
Approval |
02/20/2019 |
BENDAMUSTINE HYDROCHLORIDE ANDA #204771 |
ORIG-1 |
BENDAMUSTINE HYDROCHLORIDE |
GLENMARK PHARMS LTD |
|
Tentative Approval |
02/20/2019 |
ACYCLOVIR ANDA #205659 |
ORIG-1 |
ACYCLOVIR |
PADAGIS ISRAEL |
|
Approval |
02/20/2019 |
CISATRACURIUM BESYLATE PRESERVATIVE FREE ANDA #206791 |
ORIG-1 |
CISATRACURIUM BESYLATE |
SOMERSET THERAPS LLC |
|
Approval |
02/20/2019 |
PHYTONADIONE ANDA #210189 |
ORIG-1 |
PHYTONADIONE |
ZYDUS |
|
Approval |
02/20/2019 |
DIMETHYL FUMARATE ANDA #210390 |
ORIG-1 |
DIMETHYL FUMARATE |
TORRENT PHARMS LLC |
|
Tentative Approval |
02/21/2019 |
RINGER'S IN PLASTIC CONTAINER NDA #016693 |
SUPPL-101 |
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER NDA #018008 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) NDA #018037 |
SUPPL-73 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEPAKENE NDA #018081 |
SUPPL-69 |
VALPROIC ACID |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
DEPAKENE NDA #018082 |
SUPPL-52 |
VALPROIC ACID |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER NDA #018629 |
SUPPL-46 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEPAKOTE NDA #018723 |
SUPPL-61 |
DIVALPROEX SODIUM |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019308 |
SUPPL-30 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019308 |
SUPPL-30 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019308 |
SUPPL-30 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019308 |
SUPPL-30 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019308 |
SUPPL-30 |
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE |
BAXTER HLTHCARE |
Labeling |
Approval |
02/21/2019 |
DEPAKOTE NDA #019680 |
SUPPL-48 |
DIVALPROEX SODIUM |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
DEPACON NDA #020593 |
SUPPL-39 |
VALPROATE SODIUM |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
DEPAKOTE ER NDA #021168 |
SUPPL-39 |
DIVALPROEX SODIUM |
ABBVIE |
Labeling |
Approval |
02/21/2019 |
RENAGEL NDA #021179 |
SUPPL-37 |
SEVELAMER HYDROCHLORIDE |
GENZYME |
Labeling |
Approval |
02/21/2019 |
CIPRODEX NDA #021537 |
SUPPL-17 |
CIPROFLOXACIN; DEXAMETHASONE |
SANDOZ |
Labeling |
Approval |
02/21/2019 |
ULORIC NDA #021856 |
SUPPL-13 |
FEBUXOSTAT |
TAKEDA PHARMS USA |
Efficacy |
Approval |
02/21/2019 |
NOXAFIL NDA #022003 |
SUPPL-25 |
POSACONAZOLE |
SCHERING |
Labeling |
Approval |
02/21/2019 |
DIAZEPAM ANDA #071583 |
SUPPL-23 |
DIAZEPAM |
HOSPIRA |
Labeling |
Approval |
02/21/2019 |
DIAZEPAM ANDA #072079 |
SUPPL-32 |
DIAZEPAM |
HOSPIRA |
Labeling |
Approval |
02/21/2019 |
IBUPROFEN ANDA #078682 |
SUPPL-16 |
IBUPROFEN |
BIONPHARMA |
Labeling |
Approval |
02/21/2019 |
IBUPROFEN ANDA #078682 |
SUPPL-21 |
IBUPROFEN |
BIONPHARMA |
Labeling |
Approval |
02/21/2019 |
PREDNISONE ANDA #083677 |
SUPPL-60 |
PREDNISONE |
MYLAN |
Manufacturing (CMC) |
Approval |
02/21/2019 |
TROKENDI XR NDA #201635 |
SUPPL-20 |
TOPIRAMATE |
SUPERNUS PHARMS |
Labeling |
Approval |
02/21/2019 |
CALCITRIOL ANDA #204556 |
ORIG-1 |
CALCITRIOL |
SUN PHARM |
|
Approval |
02/21/2019 |
NOXAFIL NDA #205053 |
SUPPL-9 |
POSACONAZOLE |
MERCK SHARP DOHME |
Labeling |
Approval |
02/21/2019 |
QUDEXY XR NDA #205122 |
SUPPL-8 |
TOPIRAMATE |
UPSHER SMITH LABS |
Labeling |
Approval |
02/21/2019 |
NOXAFIL NDA #205596 |
SUPPL-8 |
POSACONAZOLE |
MERCK SHARP DOHME |
Labeling |
Approval |
02/21/2019 |
ARIPIPRAZOLE ANDA #207105 |
ORIG-1 |
ARIPIPRAZOLE |
ALKEM LABS LTD |
|
Approval |
02/21/2019 |
LUMIFY NDA #208144 |
SUPPL-1 |
BRIMONIDINE TARTRATE |
BAUSCH AND LOMB INC |
Manufacturing (CMC) |
Approval |
02/21/2019 |
EXEMESTANE ANDA #211031 |
ORIG-1 |
EXEMESTANE |
BRECKENRIDGE |
|
Approval |
02/22/2019 |
CISPLATIN NDA #018057 |
SUPPL-89 |
CISPLATIN |
HQ SPCLT PHARMA |
Manufacturing (CMC) |
Approval |
02/22/2019 |
PLATINOL NDA #018057 |
SUPPL-89 |
CISPLATIN |
HQ SPCLT PHARMA |
Manufacturing (CMC) |
Approval |
02/22/2019 |
PLATINOL-AQ NDA #018057 |
SUPPL-89 |
CISPLATIN |
HQ SPCLT PHARMA |
Manufacturing (CMC) |
Approval |
02/22/2019 |
CHLORHEXIDINE GLUCONATE NDA #020111 |
SUPPL-13 |
CHLORHEXIDINE GLUCONATE |
BAJAJ |
Labeling |
Approval |
02/22/2019 |
LANOXIN NDA #020405 |
SUPPL-15 |
DIGOXIN |
CONCORDIA |
Labeling |
Approval |
02/22/2019 |
MEPRON NDA #020500 |
SUPPL-17 |
ATOVAQUONE |
GLAXOSMITHKLINE LLC |
Labeling |
Approval |
02/22/2019 |
CAMPTOSAR NDA #020571 |
SUPPL-50 |
IRINOTECAN HYDROCHLORIDE |
PFIZER INC |
Labeling |
Approval |
02/22/2019 |
XELODA NDA #020896 |
SUPPL-42 |
CAPECITABINE |
CHEPLAPHARM |
Labeling |
Approval |
02/22/2019 |
MALARONE NDA #021078 |
SUPPL-23 |
ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
GLAXOSMITHKLINE |
Labeling |
Approval |
02/22/2019 |
MALARONE PEDIATRIC NDA #021078 |
SUPPL-23 |
ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
GLAXOSMITHKLINE |
Labeling |
Approval |
02/22/2019 |
CHANTIX NDA #021928 |
SUPPL-48 |
VARENICLINE TARTRATE |
PF PRISM CV |
Efficacy |
Approval |
02/22/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #071107 |
SUPPL-30 |
FLURAZEPAM HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
02/22/2019 |
FLURAZEPAM HYDROCHLORIDE ANDA #071108 |
SUPPL-29 |
FLURAZEPAM HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #075978 |
SUPPL-33 |
METFORMIN HYDROCHLORIDE |
HERITAGE PHARMA |
Labeling |
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #075978 |
SUPPL-34 |
METFORMIN HYDROCHLORIDE |
HERITAGE PHARMA |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #090406 |
SUPPL-6 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #090406 |
SUPPL-7 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #090406 |
SUPPL-8 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #090564 |
SUPPL-15 |
METFORMIN HYDROCHLORIDE |
GRANULES INDIA |
Labeling |
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #090888 |
SUPPL-4 |
METFORMIN HYDROCHLORIDE |
MARKSANS PHARMA |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #091155 |
SUPPL-5 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
TEVA PHARMS USA |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #091155 |
SUPPL-6 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
TEVA PHARMS USA |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #200823 |
SUPPL-7 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #200823 |
SUPPL-9 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
02/22/2019 |
PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE ANDA #200823 |
SUPPL-10 |
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
02/22/2019 |
EXEMESTANE ANDA #200898 |
SUPPL-6 |
EXEMESTANE |
ALVOGEN |
Labeling |
Approval |
02/22/2019 |
EXEMESTANE ANDA #200898 |
SUPPL-10 |
EXEMESTANE |
ALVOGEN |
Labeling |
Approval |
02/22/2019 |
FARXIGA NDA #202293 |
SUPPL-15 |
DAPAGLIFLOZIN |
ASTRAZENECA AB |
Efficacy |
Approval |
02/22/2019 |
EXEMESTANE ANDA #203315 |
SUPPL-2 |
EXEMESTANE |
RISING |
Labeling |
Approval |
02/22/2019 |
NIACIN ANDA #203742 |
ORIG-1 |
NIACIN |
RISING |
|
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #203769 |
SUPPL-9 |
METFORMIN HYDROCHLORIDE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
02/22/2019 |
METFORMIN HYDROCHLORIDE ANDA #203769 |
SUPPL-12 |
METFORMIN HYDROCHLORIDE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
02/22/2019 |
MECLIZINE HYDROCHLORIDE ANDA #205136 |
ORIG-1 |
MECLIZINE HYDROCHLORIDE |
WILSHIRE PHARMS INC |
|
Approval |
02/22/2019 |
XIGDUO XR NDA #205649 |
SUPPL-9 |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
ASTRAZENECA AB |
Efficacy |
Approval |
02/22/2019 |
GLYBURIDE ANDA #206483 |
ORIG-1 |
GLYBURIDE |
ORIENT PHARMA CO LTD |
|
Approval |
02/22/2019 |
GEMCITABINE HYDROCHLORIDE ANDA #207575 |
ORIG-1 |
GEMCITABINE HYDROCHLORIDE |
SHILPA |
|
Approval |
02/22/2019 |
LONSURF NDA #207981 |
SUPPL-8 |
TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE |
TAIHO ONCOLOGY |
Efficacy |
Approval |
02/22/2019 |
LOTEMAX SM NDA #208219 |
ORIG-1 |
LOTEPREDNOL ETABONATE |
BAUSCH AND LOMB INC |
Type 5 - New Formulation or New Manufacturer |
Approval |
02/22/2019 |
METHYLPREDNISOLONE ANDA #209097 |
ORIG-1 |
METHYLPREDNISOLONE |
CHARTWELL RX |
|
Approval |
02/22/2019 |
EXEMESTANE ANDA #209208 |
SUPPL-2 |
EXEMESTANE |
UPSHER SMITH LABS |
Labeling |
Approval |
02/22/2019 |
BUSULFAN ANDA #210148 |
ORIG-1 |
BUSULFAN |
ACCORD HLTHCARE INC |
|
Approval |
02/22/2019 |
APIXABAN ANDA #210171 |
ORIG-1 |
APIXABAN |
SUN PHARM INDUSTRIES |
|
Tentative Approval |
02/22/2019 |
EXEMESTANE ANDA #210323 |
SUPPL-1 |
EXEMESTANE |
CIPLA |
Labeling |
Approval |
02/22/2019 |
OLMESARTAN MEDOXOMIL ANDA #211049 |
ORIG-1 |
OLMESARTAN MEDOXOMIL |
SUNSHINE |
|
Approval |
02/22/2019 |
BENZONATATE ANDA #211518 |
ORIG-1 |
BENZONATATE |
ASCENT PHARMS INC |
|
Approval |
02/22/2019 |
CLOFARABINE ANDA #212034 |
ORIG-1 |
CLOFARABINE |
ACCORD HLTHCARE |
|
Approval |
02/25/2019 |
ANDROGEL NDA #021015 |
SUPPL-44 |
TESTOSTERONE |
BESINS HLTHCARE |
Labeling |
Approval |
02/25/2019 |
PROAIR HFA NDA #021457 |
SUPPL-36 |
ALBUTEROL SULFATE |
TEVA BRANDED PHARM |
Labeling |
Approval |
02/25/2019 |
ANDROGEL NDA #022309 |
SUPPL-18 |
TESTOSTERONE |
BESINS HLTHCARE |
Labeling |
Approval |
02/25/2019 |
PROTOPIC NDA #050777 |
SUPPL-21 |
TACROLIMUS |
LEO PHARMA AS |
Manufacturing (CMC) |
Approval |
02/25/2019 |
METRONIDAZOLE IN PLASTIC CONTAINER ANDA #206191 |
ORIG-1 |
METRONIDAZOLE |
INFORLIFE |
|
Approval |
02/25/2019 |
OMEGA-3-ACID ETHYL ESTERS ANDA #207420 |
ORIG-1 |
OMEGA-3-ACID ETHYL ESTERS |
ASCENT PHARMS INC |
|
Approval |
02/25/2019 |
ABIRATERONE ACETATE ANDA #208371 |
ORIG-1 |
ABIRATERONE ACETATE |
RISING |
|
Approval |
02/25/2019 |
SYMTUZA NDA #210455 |
SUPPL-5 |
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
JANSSEN PRODS |
Labeling |
Approval |
02/26/2019 |
METFORMIN HYDROCHLORIDE ANDA #076172 |
SUPPL-25 |
METFORMIN HYDROCHLORIDE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
02/26/2019 |
METFORMIN HYDROCHLORIDE ANDA #076172 |
SUPPL-27 |
METFORMIN HYDROCHLORIDE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
02/26/2019 |
METFORMIN HYDROCHLORIDE ANDA #076869 |
SUPPL-24 |
METFORMIN HYDROCHLORIDE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
02/26/2019 |
METFORMIN HYDROCHLORIDE ANDA #076869 |
SUPPL-26 |
METFORMIN HYDROCHLORIDE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
02/26/2019 |
CINVANTI NDA #209296 |
SUPPL-3 |
APREPITANT |
HERON THERAPS INC |
Efficacy |
Approval |
02/26/2019 |
AZITHROMYCIN ANDA #210000 |
ORIG-1 |
AZITHROMYCIN |
BIONPHARMA |
|
Approval |
02/26/2019 |
AZITHROMYCIN ANDA #210001 |
ORIG-1 |
AZITHROMYCIN |
BIONPHARMA |
|
Approval |
02/26/2019 |
HYDROXYZINE HYDROCHLORIDE ANDA #210634 |
ORIG-1 |
HYDROXYZINE HYDROCHLORIDE |
APOZEAL PHARMS |
|
Approval |
02/26/2019 |
CHLORTHALIDONE ANDA #211063 |
ORIG-1 |
CHLORTHALIDONE |
CHARTWELL RX |
|
Approval |
02/27/2019 |
CELLCEPT NDA #050722 |
SUPPL-38 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
02/27/2019 |
CELLCEPT NDA #050723 |
SUPPL-38 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
02/27/2019 |
CELLCEPT NDA #050758 |
SUPPL-35 |
MYCOPHENOLATE MOFETIL HYDROCHLORIDE |
ROCHE PALO |
Labeling |
Approval |
02/27/2019 |
CELLCEPT NDA #050759 |
SUPPL-43 |
MYCOPHENOLATE MOFETIL |
ROCHE PALO |
Labeling |
Approval |
02/27/2019 |
DANTROLENE SODIUM ANDA #076686 |
SUPPL-4 |
DANTROLENE SODIUM |
ELITE LABS INC |
Manufacturing (CMC) |
Approval |
02/27/2019 |
CIMZIA BLA #125160 |
SUPPL-289 |
CERTOLIZUMAB PEGOL |
UCB INC |
|
Approval |
02/27/2019 |
ESOMEPRAZOLE MAGNESIUM;NAPROXEN ANDA #202767 |
ORIG-1 |
ESOMEPRAZOLE MAGNESIUM;NAPROXEN |
ANCHEN PHARMS |
|
Tentative Approval |
02/27/2019 |
LEVOFLOXACIN ANDA #205600 |
ORIG-1 |
LEVOFLOXACIN |
MICRO LABS LTD INDIA |
|
Approval |
02/27/2019 |
ABIRATERONE ACETATE ANDA #208380 |
ORIG-1 |
ABIRATERONE ACETATE |
WOCKHARDT BIO AG |
|
Approval |
02/27/2019 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-8 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
02/27/2019 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-10 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
02/27/2019 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-11 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
02/27/2019 |
SOLIQUA 100/33 BLA #208673 |
SUPPL-7 |
INSULIN GLARGINE; LIXISENATIDE |
SANOFI-AVENTIS US |
|
Approval |
02/27/2019 |
AZACITIDINE ANDA #210748 |
ORIG-1 |
AZACITIDINE |
LUPIN LTD |
|
Approval |
02/27/2019 |
OSELTAMIVIR PHOSPHATE ANDA #211125 |
ORIG-1 |
OSELTAMIVIR PHOSPHATE |
TEVA PHARMS USA |
|
Approval |
02/27/2019 |
ADHANSIA XR NDA #212038 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
PURDUE PHARMA LP |
Type 3 - New Dosage Form |
Approval |
02/28/2019 |
CLARITIN NDA #020641 |
SUPPL-46 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/28/2019 |
CLARITIN HIVES RELIEF NDA #020641 |
SUPPL-46 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/28/2019 |
CLARITIN HIVES RELIEF REDITAB NDA #020704 |
SUPPL-34 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/28/2019 |
CLARITIN REDITABS NDA #020704 |
SUPPL-34 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/28/2019 |
CLARITIN REDITABS NDA #021993 |
SUPPL-17 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/28/2019 |
METOZOLV ODT NDA #022246 |
SUPPL-9 |
METOCLOPRAMIDE HYDROCHLORIDE |
SALIX PHARMS |
Labeling |
Approval |
02/28/2019 |
RIFADIN NDA #050420 |
SUPPL-80 |
RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
02/28/2019 |
RIFADIN NDA #050627 |
SUPPL-23 |
RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
02/28/2019 |
RIFATER NDA #050705 |
SUPPL-15 |
ISONIAZID; PYRAZINAMIDE; RIFAMPIN |
SANOFI AVENTIS US |
Labeling |
Approval |
02/28/2019 |
TERBINAFINE HYDROCHLORIDE ANDA #077511 |
SUPPL-15 |
TERBINAFINE HYDROCHLORIDE |
TARO |
Labeling |
Approval |
02/28/2019 |
OXYCODONE HYDROCHLORIDE AND IBUPROFEN ANDA #078316 |
SUPPL-7 |
IBUPROFEN; OXYCODONE HYDROCHLORIDE |
BARR LABS INC |
Labeling |
Approval |
02/28/2019 |
LEVONORGESTREL AND ETHINYL ESTRADIOL ANDA #200490 |
SUPPL-3 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
MYLAN LABS LTD |
Labeling |
Approval |
02/28/2019 |
LEVONORGESTREL AND ETHINYL ESTRADIOL ANDA #200490 |
SUPPL-4 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
MYLAN LABS LTD |
Labeling |
Approval |
02/28/2019 |
KYPROLIS NDA #202714 |
SUPPL-25 |
CARFILZOMIB |
ONYX PHARMS AMGEN |
Labeling |
Approval |
02/28/2019 |
OXYBUTYNIN CHLORIDE ANDA #211655 |
ORIG-1 |
OXYBUTYNIN CHLORIDE |
AJANTA PHARMA LTD |
|
Approval |
02/28/2019 |
HERCEPTIN HYLECTA BLA #761106 |
ORIG-1 |
TRASTUZUMAB; HYALURONIDASE-OYSK |
GENENTECH INC |
|
Approval |